Korea BioNews
Total 367 Article , currentpage 24 /Total Page RSS
| No | SUBJECT | SOURCE | DATE | COUNT |
|---|---|---|---|---|
| 137 | Korean bio players pursue new drug formulations for convenience, competitiveness | Pulse | 2023-11-17 | 5 |
| 136 | Korean pharmaceuticals turn to Humira biosimilars | Pulse | 2023-11-17 | 5 |
| 135 | [Herald Interview] Daewoong Pharmaceutical steps onto global stage | The Korea Herald | 2023-11-17 | 4 |
| 134 | Samsung Biologics signs W511b deal with Novartis | The Korea Herald | 2023-11-17 | 7 |
| 133 | SK Bioscience taps ASEAN vaccine market with Thai drug firm | The Korea Herald | 2023-11-17 | 6 |
| 132 | Samsung Biologics lands further Pfizer deals in record year | Korea JoongAng Dail... | 2023-11-17 | 4 |
| 131 | Nearly 550 S. Korean bio firms to attend Bio Int'l Convention | Yonhap News Agency | 2023-11-16 | 4 |
| 130 | Hanmi Pharm’s investigational therapy gets fast-track designation from U.S. | Pulse | 2023-11-16 | 4 |
| 129 | Daesang begins production of bioplastic ingredient | The Korea Herald | 2023-11-16 | 5 |
| 128 | Celltrion aims to gain approvals for 5 biosimilars this year | The Korea Herald | 2023-11-16 | 6 |